PATIENT MARKETING REPORT: GROUP THERAPY

It doesn’t take several years of post-graduate studies and a degree in medicine to describe what it’s like to live with a disease. From a patient’s perspective, the practical wisdom available in an embar-rassing anecdote, or a triumphant description of a breakthrough,can sometimes provide more value than any discussion to be had inside a doctor’s…

PRESENTATION OF VERILOGUE DATA AT UPCOMING EYE FOR PHARMA CONFERENCE REVEALS HOW TO IDENTIFY AND OVERCOME PATIENT ADHERENCE CHALLENGES

WHO: Jeffrey Dierks, Senior Product Director, Endo Pharmaceuticals WHAT: “Adherence as part of a commercial strategy: How to create value through communication and co-ordination, leading to better relationships with patients” This presentation will include information that demonstrates how the analysis of real-life, in-office dialogue between patients and physicians is critical to revealing concrete and specific recommendations…

TRACKING THE EVOLUTION OF ONCOLOGY DRUG PRESCRIBING

Do you know what your cancer drug is up to? Answering that question is not as simple as for medicines taken by well-defined patient groups, or principally for one disease. Yet among drug classes oncology treatments hold a unique position: A frightening disease of immense scientific interest, hundreds of pipeline drugs and nearly as many…

MEDADNEWS: LITTLE EMPATHY FOR SIDE EFFECT FEARS

Generalized fears about taking medications are common among patients, according to a new study issued by Verilogue exploring the actual fears and concerns patients most frequently discuss in their doctors’ offices and how doctors respond to them. The review of 23,923 naturally occurring patient-doctor interactions across 14 specialties during the course of 18 months found…

MEDADNEWS: SPECIALTY REPS: THE SMALLER, SMARTER SALES FORCE

The pharmaceutical sales force is undergoing a dra-matic evolution as the pharmaceutical industry shifts from pri-mary-care drugs to biotechnology and specialist medicines. To effectively promote this changing product mix, marketers must adapt their sales and marketing models. In particular, marketers need sales representatives with more clinical knowledge, patient focus, managed-care fluency, and understanding of territories.…

FDA FILES: A MORE TRANSPARENT FDA

FDA is under new management. Margaret Hamburg, M.D., was sworn in to her position as FDA commissioner May 22, 2009, by Health and Human Services Secretary Kathleen Sebelius. Dr. Hamburg is an authority on global health,public health systems, infectious disease, bioterrorism, and emergency preparedness. She served as the Nuclear Threat Initiative’s founding VP for the…

MEDADNEWS: PHYSICIANS DRIVE VACCINE DIALOGUE

Vaccines are anticipated to be one of the fastest-growing segments of the pharmaceutical market between 2008 and 2023. Analysts believe that new legislation, advancements in science, and enhanced vaccine awareness are contributing to vaccines growth, particularly in the United States. Recent growth of vaccines, such as sales of Merck & Co.’s blockbuster cervical cancer vaccine…

VERILOGUE FEATURED IN BUSINESS WEEK ONLINE

Don’t spend precious resources wooing early-stage investors. First build your business, then seek funding that can help you grow It’s the ongoing irony of early-stage investing: Just when your little-engine-that-could startup desperately needs funding, sophisticated investors have no interest in parting with their money. Not for a startup, not right now. But once your company…

VERILOGUE GUEST PRESENTER AT 2008 PMRG CONFERENCE

FORT WASHINGTON, Pa, October 14, 2008 – Verilogue, a leading pharmaceutical market research firm that captures and analyzes authentic physician-patient interactions, will discuss the opportunities that exist to understand and shape customer attitudes and behaviors at the clinical point-of-practice. Specifically, Verilogue’s case study presentation at the Pharmaceutical Market Research Group (PMRG) Institute in Philadelphia later this…

VERILOGUE UNVEILS REAL PATIENT CONCERNS RELATED TO HIGH CHOLESTEROL AT THIS YEAR’S AACH CONFERENCE

FORT WASHINGTON, PA, October 13, 2008 – One of the biggest challenges facing primary care physicians treating patients with high cholesterol is getting patients to agree and adhere to recommended treatments, be they in the form of pharmaceutical therapy, lifestyle modifications, or a combination of each. At the annual American Academy of Communication in Healthcare (AACH…